Search research articles
Contact Us
Filters
Showing results (131-140 of 165) with videos related to
Page
of 17
Sort By:
Peptides
|
July 1, 1990
Vasopressin antisense peptide interactions with the V1 receptor
J M Kelly, D Trinder, P A Phillips, et al.
Clinical and Experimental Pharmacology & Physiology
|
April 1, 1990
Reduced V1 vasopressin binding in the rat nucleus solitarii after nodose ganglionectomy
P A Phillips, R E Widdop, S Y Chai, et al.
Neuroscience
|
December 1, 1988
Localization of vasopressin binding sites in rat brain by in vitro autoradiography using a radioiodinated V1 receptor antagonist
P A Phillips, J M Abrahams, J Kelly, et al.
Clinical Science (London, England : 1979)
|
October 1, 1994
Vascular responses to vasopressin antagonists in man and rat
L M Burrell, P A Phillips, K A Rolls, et al.
Age and Ageing
|
September 1, 1987
Altered water excretion in healthy elderly men
M J Crowe, M L Forsling, B J Rolls, et al.
American Journal of Clinical Pathology
|
June 1, 1987
Evaluation of the Coulter S-Plus IV three-part differential as a screening tool in a tertiary care hospital
M K Miers, A B Fogo, C F Federspiel, et al.
Clinical Science (London, England : 1979)
|
June 1, 1995
Down-regulation of vasopressin V1a receptor mRNA in diabetes mellitus in the rat
P A Phillips, J Risvanis, A M Hutchins, et al.
International Journal of Clinical Practice
|
September 23, 2009
Unperceived treatment gaps in acute coronary syndromes
L T Huynh, D P B Chew, R M Sladek, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1988
Vasopressin receptors in rat brain and kidney: studies using a radio-iodinated V1 receptor antagonist
P A Phillips, J M Kelly, J M Abrahams, et al.
The American Journal of Physiology
|
February 1, 1997
Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR
M Naitoh, L M Burrell, J Risvanis, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 165) with videos related to
Sort By:
Page
of 17
Peptides
|
July 1, 1990
Vasopressin antisense peptide interactions with the V1 receptor
J M Kelly, D Trinder, P A Phillips, et al.
Clinical and Experimental Pharmacology & Physiology
|
April 1, 1990
Reduced V1 vasopressin binding in the rat nucleus solitarii after nodose ganglionectomy
P A Phillips, R E Widdop, S Y Chai, et al.
Neuroscience
|
December 1, 1988
Localization of vasopressin binding sites in rat brain by in vitro autoradiography using a radioiodinated V1 receptor antagonist
P A Phillips, J M Abrahams, J Kelly, et al.
Clinical Science (London, England : 1979)
|
October 1, 1994
Vascular responses to vasopressin antagonists in man and rat
L M Burrell, P A Phillips, K A Rolls, et al.
Age and Ageing
|
September 1, 1987
Altered water excretion in healthy elderly men
M J Crowe, M L Forsling, B J Rolls, et al.
American Journal of Clinical Pathology
|
June 1, 1987
Evaluation of the Coulter S-Plus IV three-part differential as a screening tool in a tertiary care hospital
M K Miers, A B Fogo, C F Federspiel, et al.
Clinical Science (London, England : 1979)
|
June 1, 1995
Down-regulation of vasopressin V1a receptor mRNA in diabetes mellitus in the rat
P A Phillips, J Risvanis, A M Hutchins, et al.
International Journal of Clinical Practice
|
September 23, 2009
Unperceived treatment gaps in acute coronary syndromes
L T Huynh, D P B Chew, R M Sladek, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1988
Vasopressin receptors in rat brain and kidney: studies using a radio-iodinated V1 receptor antagonist
P A Phillips, J M Kelly, J M Abrahams, et al.
The American Journal of Physiology
|
February 1, 1997
Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR
M Naitoh, L M Burrell, J Risvanis, et al.
Page
of 17